Cardio Partners, a Sarnova company, Acquires Allied 100

Cardio Partners, Inc., a company of Sarnova, Inc. and a national leader in providing emergency preparedness solutions, announced today that it has acquired Allied 100, LLC, a nationwide distributor of automated external defibrillators (AEDs) and related accessories, from Ridgemont Equity Partners. The sale closed on September 3, 2021.

Based in Wisconsin, Allied 100 is comprised of trusted cardiac response brands including; AED Superstore, Heartsmart, SOS Technologies, CPR Plus and Annuvia. The combination of Cardio Partners and Allied 100 will provide expanded sudden cardiac arrest (SCA) solutions, training and services to both professional and bystander first responder markets.

Brian LaDuke, President of Emergency Preparedness at Sarnova, commented that, “Over 365,000 out-of-hospital sudden cardiac arrests happen each year in the United States. Combining these companies expands our reach and offering, creating a full sudden cardiac arrest solution enabling more customers the opportunity to respond in an emergency and increase the chances that a life is saved.”

“The Allied 100 team welcomes the opportunity to join Cardio Partners, another customer-centric company, to offer expanded services to our customers,” said Mike Berg, CEO Allied 100. “This combination strengthens and brings emergency preparedness to the forefront in the communities and workplaces we live and work.”

Both Cardio Partners and Allied 100 have robust AED and emergency preparedness products and service solutions to help customers save minutes and save lives. “Allied 100’s strength in excellent customer service and online product sales complements Cardio Partners’ offering of nationwide training and large-scale field deployments of SCA solutions,” said Niraj Patel, General Manager of Cardio Partners. “Expanding to two distribution hubs will also help speed delivery of much needed life-saving products to all customers,” he added.

With significant investment from Sarnova, and Sarnova’s owner Patricia Industries, Cardio Partners aims to expand its operations and customer base. “We are excited to combine these two leading companies and continue to invest in emergency preparedness, CPR training and AED program management services,” said Jeff Prestel, CEO Sarnova.

“Patricia Industries is committed to supporting Cardio Partners and Sarnova in their mission to bring a comprehensive SCA solution to customers nationwide,” said Yuriy Prilutskiy, Head of Patricia Industries North America, a part of Investor AB. “This transaction further supports Sarnova’s long-term growth and aligns with our organization’s purpose of creating value for people and society by building strong and sustainable businesses.”

Patricia/Sarnova was represented by Harris Williams LLC (financial advisor) and Simpson Thatcher & Bartlett LLP (legal advisor). Ridgemont/Allied 100 was advised by Robert W. Baird & Co. (financial advisor) and K&L Gates LLP (legal advisor).

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”